Nachrichten zur Hims & Hers Health Aktie

Barclays cuts Hims and Hers stock price target on margin pressure

Barclays cuts Hims and Hers stock price target on margin pressure…

Hims & Hers Health (NYSE: HIMS) CEO Disposes Of 78,859 Shares In Routine Tax Withholding Event

Hims & Hers Health, Inc. (NYSE: HIMS) CEO Andrew Dudum disposed of 78,859 shares of Class A Common Stock on…

Hims & Hers CEO Defends Data Practices, Projects Sharp Drop in Weight-Loss Drug Prices

Hims & Hers Health CEO Andrew Dudum defended the telehealth company against an FTC lawsuit over data sharing and billing…

Hims & Hers Health (NYSE:HIMS) Stock Price Up 10.8%

Hims & Hers Health (NYSE:HIMS) Trading 10.8% Higher - Heres Why…

Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access

Hims & Hers CEO Andrew Dudum defends the firm against an FTC lawsuit, discusses dropping GLP-1 drug prices and reveals…

Hims & Hers: Buying The Margin Dip

Hims & Hers Health is rated a buy at current levels, driven by robust international expansion and product innovation. Read…

Hims & Hers Health (HIMS) Adds AI Weight Loss Care And Smart Scale

Hims & Hers Health (NYSE:HIMS) introduced an AI-powered care experience tailored for Hers weight loss members, embedding AI and provider…

Hims & Hers CEO: FTC Suit Misses the Point

Hims & Hers CEO defends care model amid FTC suit, predicts GLP-1 costs to $40-$50, and notes Novo dropped patent…

Hims & Hers Chief Accounting Officer Is Leaving. Heres What Her Latest Insider Filing Shows

This filing notes that shares were withheld automatically to cover tax obligations from quarterly RSU vesting.…

Hims & Hers Policy Chief Just Filed an Insider Transaction. Heres What It Means.

This non-discretionary sale was tied to RSU tax withholding; the insider retains 65,734 direct shares and 428,000 derivative securities, per…

Hims & Hers CEO Just Disposed of 78,859 Shares. Heres What Long-Term Investors Should Know.

Stock-based compensation vesting triggered mandatory tax withholding, but Dudum retains about 9.7 million shares worth $272 million.…

Hims & Hers CEO on how firms with large datasets can cut AI costs

He said big patient datasets are Hims & Hers "real asset," as they can be used to train open-weight models.…

Wellness Briefing: Hims & Hers plots rapid expansion into peptide therapies like BPC-157, plus news

For the Wellness Briefing, Glossy is unpacking Hims & Hers Q2 earnings meeting where CEO Andrew Dudum explained the telehealth’s…

Hims & Hers Health sees 17x international revenue growth, targets $600M+ by 2026 with AI and new therapies.

Hims & Hers Health has experienced a significant surge in international revenue, growing over 17-fold year-over-year to $131 million, driven…

Is Hims & Hers Health Inc (HIMS) a Bargain After 4.3% Drop? GF Value Says Undervalued

On August 18, 2026, Hims & Hers Health Inc (HIMS) shares fell 4.3% to $27.39, continuing a downward trend that…

Why Is Hims & Hers Health (HIMS) Facing A New Privacy Lawsuit?

Hims & Hers Health (NYSE:HIMS) is facing a new consumer class action lawsuit alleging misrepresentation of user privacy and unauthorized…

Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells $261,831.32 in Stock

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 9,388 shares of the companys stock…

Oluyemi Okupe Sells 55,383 Shares of Hims & Hers Health (NYSE:HIMS) Stock

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 55,383 shares of the companys stock…

Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following Major FTC Lawsuit Over Privacy & Billing; Hagens Berman Investigates Corporate Compliance and Investor Ramifications

Investors who lost money in HIMS after its stock plunged due to allegedly misleading financial statements are urged to contact…

HIMS Looks 34.0% Undervalued on GF Value™ Despite Profitability Challenges

On August 18, 2026, Andrew Dudum, CEO of Hims & Hers Health Inc (NYSE: HIMS), addressed the companys ongoing FTC…

Hims CEO responds to FTC suit, sees GLP-1 prices falling to $40-$50: CNBC

Hims & Hers (HIMS) CEO defends against FTC lawsuit, predicts GLP-1 prices could fall to $40–$50/month, and shares AI-native strategy.…

Hims & Hers CEO is pushing back on FTC lawsuit over health data sharing

Andrew Dudum told CNBC the agency wanted "more of a headline than a real agreement" after years of cooperative talks…

Hims & Hers CEO Andrew Dudum Says AI Health Coach Could Be Just 12 Months Away, Believes It Could Increase Medication Adherence

Speaking in an interview with CNBC on Tuesday, Dudum said an AI coach could remind patients to take their medicine,…

Watch CNBCs full interview with Hims & Hers CEO Andrew Dudum

In an exclusive interview, Hims & Hers CEO Andrew Dudum sits down with Squawk Box Co-Anchor Andrew Ross Sorkin and…

Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"

Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"…

Hims & Hers CEO Tells the FTC That Regulators Just Don’t Understand

Andrew Dudum explained CNBC that the FTC’s lawsuit is just a misunderstanding of what he’s doing... but maybe the regulator…

Hims & Hers CEO says FTC lawsuit misunderstands how the company works

Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTCs lawsuit against the company, compounded GLP-1 drugs and…

Hims & Hers: Eucalyptus Deal Unlocks New Markets

Hims & Hers (HIMS) is rated Hold as current market prices exceed my implied fair value of $22 per share.…

Hims & Hers Health Stock Short Interest Rises to 32.05%

Hims & Hers Health short interest was 32.05% of the float on July 31st, according to new data we received…

Hims & Hers CEO on AI in healthcare, GLP-1 drugs and tackling healthcare affordability

Hims & Hers co-founder and CEO Andrew Dudum joins Squawk Box to discuss the companys AI investment, how AI will…

Hims & Hers Chief Accounting Officer Irene Becklund to Leave in October

Hims & Hers Chief Accounting Officer Irene Becklund will leave the company on October 9 after more than seven years,…

Kaplan Fox Announces an Investigation Into Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Securities Law Violations

NEW YORK, NY - August 18, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims…

Him & Hers CEO Andrew Dudum on the companys approach to AI agents

Hims & Hers co-founder and CEO Andrew Dudum joins Squawk Box to discuss how the company is integrating AI tools,…

Hims & Hers Health (HIMS) Is Down 9.9% After FTC And Class Action Privacy Allegations

Earlier this month, Hims & Hers Health faced intensified legal pressure as the FTC, joined by California and Utah authorities,…

HIMS Stock Has Quadrupled In 5 Years: How Hims Turned A $3 Stock Into A Telehealth Giant

Hims & Hers Health (HIMS) marked its fifth anniversary as a publicly traded company on Monday, capping a volatile journey…

Hims & Hers faces FTC lawsuit over privacy breaches, stock drops 14%.

Hims & Hers Health, Inc. is under investigation after the FTC sued the company for allegedly sharing customers medical information…

Hims & Hers Stock (HIMS) Opinions on Five-Year Public Listing Anniversary

Five-Year Milestone: Social media users marked Hims & Hers Healths fifth anniversary as a public company with notable enthusiasm, highlighting…

Hims & Hers Health (Backpack Securities) Analytics: Price Dynamics, Quarterly Returns, and Annual Price Changes in USD

Comprehensive analysis of Hims & Hers Health (Backpack Securities) price dynamics, quarterly returns, and annual trends in dollars. Our detailed…

Hims & Hers Health (Backpack Securities) Price | HIMS Price Today, Live Chart, USD converter, Market Capitalization

Current Hims & Hers Health (Backpack Securities) (HIMS) token data: Price $ 0.00, Trading Volume $ 0.00, Market Cap $…

Hims & Hers Health: Growth Story Shakes Investor Nerves

Hims & Hers Health ( ($HIMS) ) has fallen by -11.39%. Read on to learn why. Hims & Hers Health…

Hims & Hers Health (NYSE:HIMS) Upgraded to Hold at Wall Street Zen

Wall Street Zen raised shares of Hims & Hers Health from a "sell" rating to a "hold" rating in a…

Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?

Hims & Hers Health, Inc. (NYSE:HIMS) shares fell over 6% in extended trading on August 10 after the telehealth company…

Hims & Hers Healths Next Act: Making Its Own Drugs Again

Hims & Hers (HIMS) buy rating: 2Q revenue +38%, raised FY outlook, margin pressure from branded GLP-1s; peptides may lift…

Hims & Hers Health, Inc. • Robinhood Token Price, HIMS Price, Live Charts, and Marketcap

Hims & Hers Health, Inc. • Robinhood Token (HIMS) Price INR Today is ?2,818.85. News, predictions, charts, market cap, buy,…

FTC lawsuit alleges Hims & Hers charged consumers for unwanted prescriptions

A new lawsuit, led by the Federal Trade Commission (FTC), alleges Hims & Hers Health charged consumers for prescription medication…

Kaplan Fox is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Securities Law Violations

NEW YORK, NY - August 13, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims…

HIMS SHAREHOLDER ALERT: Hims & Hers Health, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Hims & Hers Health, Inc.…

HIMS SHAREHOLDER ALERT: Hims & Hers Health, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Hims & Hers Health, Inc.…

FTC and States Sue Hims & Hers Over Privacy and Billing Practices

The Federal Trade Commission (FTC), joined by the States of California and Utah, has filed a lawsuit against telehealth company…

As Hims prepares for peptides launch, Wall Street cautious on prospects this year

Hims & Hers Health plans to offer some legally available peptides in 2026, but investors and analysts who spoke to…